Table 2.
Freedom from recurrence (FFR), freedom from local recurrence as the first site of failure (FFLR) and freedom from distant metastases as the first site of failure (FFDM) as a function of FIGO stage, immunohistochemical score (IHC), pathologic nodal status at surgery and histology on univariate analysis.
| Grouping Variable | 5-yr Overall FFR | 5-yr FFLR | 5-yr FFDM |
|---|---|---|---|
| All Eligible Patients | 65% | ||
| FIGO Stage: | 100% vs 67% vs 13% | ||
| IA vs IB vs IIA | (p = 0.019) | ||
| IHC: | 71% vs 62% | 73% vs 74% | 92% vs 76% |
| <30 vs ≥30 | (p = 0.45) | (p = 0.87) | (p=0.040) |
| Lymph Nodes: | 40% vs 73% | 61% vs 76% | 55% vs 90% |
| Positive vs Negative | (p = 0.0013) | (p = 0.18) | (p < 0.0001) |
| Histology: | 62% vs 76% | 67% vs 90% | 83% vs 79% |
| Squamous vs Other | (p = 0.076) | (p = 0.0070) | (p = 0.70) |
| Age: | 64% vs 68% | 69% vs 79% | 81% vs 83% |
| <45 vs ≥45 years old | (p = 0.98) | (p = 0.50) | (p = 0.81) |